Related Experiment Video

Updated: May 21, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K

Aflibercept biosimilars - so near, yet so far

Ashish Sharma1, Se Joon Woo2, Baruch D Kuppermann3

  • 1Lotus Eye Hospital and Institute, Coimbatore, India.

Expert Opinion on Biological Therapy
|March 19, 2025
PubMed
Summary

No abstract available in PubMed .

Keywords:
Aflibercept biosimilarEyleaanti-VEGFpatentretina

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.3K
Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.2K

Related Experiment Videos

Last Updated: May 21, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.3K
Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.2K

Related Concept Videos

Bioequivalence: Overview01:16

Bioequivalence: Overview

901
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
901

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.

Pleura and peritoneum·2021

TilGAN: GAN for Facilitating Tumor-Infiltrating Lymphocyte Pathology Image Synthesis With Improved Image Classification.

IEEE access : practical innovations, open solutions·2021

Thoracic endovascular aortic repair for aortobronchial fistula: a case series.

European heart journal. Case reports·2021

Enhanced Safety of Pedicle Subtraction Osteotomy Using Intraoperative Ultrasound.

World neurosurgery·2021

Neuroprotective Effects of Fluoxetine on Molecular Markers of Circadian Rhythm, Cognitive Deficits, Oxidative Damage, and Biomarkers of Alzheimer's Disease-Like Pathology Induced under Chronic Constant Light Regime in Wistar Rats.

ACS chemical neuroscience·2021

Quality assurance in radiation oncology.

Pediatric blood & cancer·2021

Persistent subretinal fluid in neovascular AMD: clinical significance and implications for treatment.

Expert opinion on biological therapy·2026

Combining biological matrices with growth factor concentrates: toward standardized protocols in regenerative medicine.

Expert opinion on biological therapy·2026

Originator versus biosimilar adalimumab in hidradenitis suppurativa: a real-world cohort study.

Expert opinion on biological therapy·2026

Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study.

Expert opinion on biological therapy·2026

Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.

Expert opinion on biological therapy·2026

Gene therapy approaches for inborn errors of immunity: from bench to bedside.

Expert opinion on biological therapy·2026

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment.

Journal of the American College of Cardiology·2026

2026 Update on Clinical Trials in β-Thalassemia.

American journal of hematology·2026

Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.

... International Conference on Learning Representations·2026

Artificial intelligence in trichology: A systematic review of current applications in diagnosis, severity assessment, and treatment monitoring.

Digital health·2026

Durable LVAD therapy in end-stage methamphetamine-associated heart failure: a case report of the bridge to opportunity and transplant candidacy.

European heart journal. Case reports·2026

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Frontiers in cellular and infection microbiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us